The possible mechanism of GM dysbiosis associated with cardiovascular diseases involves the participation of intestinal microbiota in increasing intestinal permeability and inducing inflammation via the LPS/TLR4 signalling pathways and the NLRP3 pathways, thereby contributing to the development of cardiovascular diseases [193]. The gene discussed is NLRP3; the disease is cardiovascular disorder.